Roche, the makers of ocrelizumab have today announced that the Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion for the use of ocrelizumab in adults with active relapsing remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS)...Read more - http://www.ms-uk.org/ocrelizumab-gains- ... s-and-ppms
Ocrelizumab gains positive CHMP opinion for RRMS and PPMS
Ocrelizumab gains positive CHMP opinion for RRMS and PPMS
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 10561 Views
-
Last post by NHE
-
- 0 Replies
- 1002 Views
-
Last post by NHE
-
- 2 Replies
- 1103 Views
-
Last post by NHE
-
- 8 Replies
- 7280 Views
-
Last post by Algis
-
- 0 Replies
- 1532 Views
-
Last post by NHE
-
- 0 Replies
- 596 Views
-
Last post by DIM
-
- 0 Replies
- 2278 Views
-
Last post by NHE
-
- 1 Replies
- 1279 Views
-
Last post by vesta
-
- 0 Replies
- 1395 Views
-
Last post by NHE